Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(3R,7R,25R,28R)-33-(4-(4-(((2S,3R)-1-(((2aS,4R,4aR,6S,9R,11R,12R,12aS,12bR)-12b-acetoxy-12-(benzoyloxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-9-yl)oxy)-3-((tert-butoxycarbonyl)amino)-1-oxo-3-phenylpropan-2-yl)oxy)-4-oxobutyl)-1H-1,2,3-triazol-1-yl)-12,25,28-tribenzyl-5,13,20,23,26,29-hexaoxo-4,6,12,19,24,27,30-heptaazatritriacontane-1,3,7-tricarboxylic acid
ID: ALA5198326
PubChem CID: 168287716
Max Phase: Preclinical
Molecular Formula: C99H125N11O27
Molecular Weight: 1901.14
Associated Items: